Answer
Deucravacitinib should preferably be avoided during pregnancy as a precaution because human pregnancy data are limited, although animal studies do not indicate direct or indirect harmful effects on reproduction.
Sources for this answer
- SOTYKTU 6 mg film coated tabletsBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked